To evaluate the impact of intravenous ferric carboxymaltose on secondary clinical outcomes in patients with chronic heart failure and iron deficiency in the randomized, double-blind, placebo-controlled trial of 135 patients with at least NYHA class II heart failure and 1 or more iron-deficiency criteria. Participants were randomized into the intervention (n = 68) and control groups (n = 67), with a 24-week follow-up. The composite endpoint was the change in the clinical status as measured by NYHA functional class, the Kansas City Cardiomyopathy Questionnaire (KCCQ), NT-proBNP, 6-minute walking distance (6MWD), and the number of heart failure hospitalizations. Major statistically significant benefits seen in the IV iron cohort compared with placebo were NYHA functional class improvement (≥1 class: 62% vs. 31%, p < 0.001), KCCQ scores (+18.6 vs. +6.2, p < 0.001), NT-proBNP levels (−420 vs. −110 pg/mL, p < 0.001), 6MWD (+64 vs. +24 meters, p < 0.001), and fewer hospitalizations (13.2% vs. 28.4%, p = 0.032). In our studied population, the administration of intravenous iron improves very significantly clinical condition, functional capacity and biological parameters, and also helps to reduce the number of hospitalizations in patients with chronic heart failure with reduced ejection fraction and deficiency of iron. The drug was well tolerated, with no meaningful differences in adverse events between the groups.
| Mualliflar | Рахмонов Сардор Темиркул угли, Ибрагимов Хасан Исмоилович |
|---|---|
| Jurnal | Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali |
| Nashr sanasi | 2025-06-06 |
| Jild | 6 |
| Son | 2 |
| Til | Rus |
сердечная недостаточность, дефицит железа, внутривенное железо, карбоксимальтозат железа, клинические исходы, функциональная способность, yurak yetishmovchiligi, temir tanqisligi, tomir ichiga yuboriladigan temir, karboksimaltozat temiri, klinik natijalar, funksional imkoniyat
In our study, we studied a total of 54 patients with gout. Among them, 36 patients (72%) had arterial hypertension. In our study, patients were divided into 2 large groups according to the course of gout: patients with…
The study demonstrated a significant contribution to the development of acute forms of coronary heart disease, such as age, physical inactivity, chronic liver disease, and in men - tobacco use, dyslipidemia…
Cardiovascular diseases (CVD) remain one of the leading causes of mortality and disability among women over 40 years old. In recent decades, there has been an increase in comorbid conditions, among which metabolic…
Introduction. Acute myocardial infarction (AMI) is one of the leading causes of death worldwide, and its combination with atrial fibrillation (AF) significantly aggravates the course of the disease and increases the…
The problem of kidney dysfunction and its impact on outcomes in different groups of cardiac patients continue to being widely used. Kidney dysfunction is associated with a number of traditional cardiovascular risk…
This study aims to investigate the problem of hypertension in pregnancy (HG)directed. 200 pregnant women in Samarkand, Uzbekistan participated in the study. In this study, 25% of the participants were diagnosed with…
It is known that the main component of the prevention of cardiovascular events in patients after myocardial infarction is dual antiplatelet therapy (DAPT) The aim of the research was to study the effect of obesity…
Arterial hypertension (AH) is one of the main factors in the development of chronic heart failure (CHF), associated with impaired left ventricular (LV) diastolic function. The purpose of the study was to evaluate the…
Purpose of the research. Conduct an analysis of modern epidemiological risk factors for the realization of latent tuberculosis infection into local forms of tuberculosis in children living in tuberculosis infection…
Hypertension in the elderly is a serious medical problem that requires attention, as it increases the risk of developing many diseases that worsen the quality of life. With age, blood vessels become stiffer and less…
Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar